Drug Profile
Research programme: cancer diagnostics and therapeutics - A*STAR/Roche
Latest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator Agency for Science, Technology and Research
- Developer Agency for Science, Technology and Research; Roche
- Class Monoclonal antibodies; Monoclonal antibody diagnostics
- Mechanism of Action Cell death stimulants; Cellular structure modulators; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for research development in Cancer in Singapore
- 28 Aug 2018 No recent reports of development identified for research development in Cancer(Diagnosis) in Singapore
- 14 Jul 2014 Early research in Cancer in Singapore (unspecified route)